Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Liberia receives ebola serum supply
Medical imagery
The serum treatment will be monitored by doctors in Liberia (stock photo)
Treatment is made from the blood of recovered survivors

Liberia has started to treat patients infected with Ebola with serum therapy - a treatment made from the blood of recovered survivors, the BBC reports.

It is hoped that the experimental treatment will help combat the virus that has been killing thousands of people throughout West Africa.

The ebola serum is made from the blood of survivors, which contain antibodies to fight off the virus. It is made by removing the red blood cells, whilst keeping the important antibodies - which can be used to treat other patients.

In the UK and US, Ebola patients have already received this form of treatment.

The serum treatment will be monitored by doctors in Liberia, who will monitor how safe and effective the therapy is.

A number of Liberian health care workers have been trained to give the serum.

Dr David Hoover, the programme's director, said: "This will empower local health care systems to become more self-sufficient and better serve their patients during this current epidemic as well as in the future."

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.